Literature DB >> 8921170

Cloning of murine LAG-3 by magnetic bead bound homologous probes and PCR (gene-capture PCR).

R Mastrangeli1, E Micangeli, S Donini.   

Abstract

In recent years PCR-based gene cloning strategies have found wide application in molecular biology, due to the power, speed, and relative simplicity of the PCR methodology. We have set up a novel PCR cloning strategy to isolate homologous genes, which is based on the capture of the cDNA sequence(s) of interest with a biotinylated probe and streptavidin-coupled magnetic beads followed by PCR amplification of the selected molecules. This method does not require sequence information on 5' and 3' regions of the cDNA of interest and permits gene isolation to be sensitive, fast, simple, and specific even when the conventional screening procedures give rise to high backgrounds. By using this technique, which we propose to call gene-capture PCR (GC-PCR) cloning, we were able to isolate the full-length murine lymphocyte activation gene 3 (LAG-3) cDNA from total RNA of activated thymocytes. The GC-PCR technique represents a powerful tool for easy isolation not only of homologous genes from related species, but also of genes sharing conserved regions of suitable length, gene variants, and gene encoding proteins where only limited knowledge of the amino acid sequence exists.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8921170     DOI: 10.1006/abio.1996.0382

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  9 in total

1.  Characterization of the major histocompatibility complex class II binding site on LAG-3 protein.

Authors:  B Huard; R Mastrangeli; P Prigent; D Bruniquel; S Donini; N El-Tayar; B Maigret; M Dréano; F Triebel
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

Review 2.  LAG3 (CD223) as a cancer immunotherapy target.

Authors:  Lawrence P Andrews; Ariel E Marciscano; Charles G Drake; Dario A A Vignali
Journal:  Immunol Rev       Date:  2017-03       Impact factor: 12.988

Review 3.  Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts.

Authors:  Yuchen Wang; Hao Zhang; Chao Liu; Zeyu Wang; Wantao Wu; Nan Zhang; Longbo Zhang; Jason Hu; Peng Luo; Jian Zhang; Zaoqu Liu; Yun Peng; Zhixiong Liu; Lanhua Tang; Quan Cheng
Journal:  J Hematol Oncol       Date:  2022-08-17       Impact factor: 23.168

4.  Detection and Capturing of (14)C Radioactively-Labeled Small Subunit rRNA from Mixed Microbial Communities of a Microbial Mat Using Magnetic Beads.

Authors:  Raeid M M Abed
Journal:  Indian J Microbiol       Date:  2011-10-28       Impact factor: 2.461

5.  Linking microbial community function to phylogeny of sulfate-reducing Deltaproteobacteria in marine sediments by combining stable isotope probing with magnetic-bead capture hybridization of 16S rRNA.

Authors:  Tetsuro Miyatake; Barbara J MacGregor; Henricus T S Boschker
Journal:  Appl Environ Microbiol       Date:  2009-06-05       Impact factor: 4.792

6.  LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model.

Authors:  Ruea-Yea Huang; Cheryl Eppolito; Shashikant Lele; Protul Shrikant; Junko Matsuzaki; Kunle Odunsi
Journal:  Oncotarget       Date:  2015-09-29

Review 7.  LAG3's Enigmatic Mechanism of Action.

Authors:  Colin G Graydon; Shifa Mohideen; Keith R Fowke
Journal:  Front Immunol       Date:  2021-01-08       Impact factor: 7.561

Review 8.  Understanding LAG-3 Signaling.

Authors:  Luisa Chocarro; Ester Blanco; Miren Zuazo; Hugo Arasanz; Ana Bocanegra; Leticia Fernández-Rubio; Pilar Morente; Gonzalo Fernández-Hinojal; Miriam Echaide; Maider Garnica; Pablo Ramos; Ruth Vera; Grazyna Kochan; David Escors
Journal:  Int J Mol Sci       Date:  2021-05-17       Impact factor: 5.923

9.  Development of a novel human phage display-derived anti-LAG3 scFv antibody targeting CD8+ T lymphocyte exhaustion.

Authors:  Alessandro Ascione; Claudia Arenaccio; Alessandra Mallano; Michela Flego; Mara Gellini; Mauro Andreotti; Craig Fenwick; Giuseppe Pantaleo; Stefano Vella; Maurizio Federico
Journal:  BMC Biotechnol       Date:  2019-10-17       Impact factor: 2.563

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.